Concepedia

811MO Maintenance olaparib for patients (pts) with newly diagnosed, advanced ovarian cancer (OC) and a BRCA mutation (BRCAm): 5-year (y) follow-up (f/u) from SOLO1

Susana Banerjee, Kathleen N. Moore, Nicoletta Colombo, Giovanni Scambia, B-G. Kim, Ana Oaknin, Michael Friedländer, Alla Lisyanskaya, Anne Floquet, Alexandra Léary,

Annals of Oncology · 2020 · 67 citations · 0 references

Open access

Concepts

MedicineGynecologyOncologyChemotherapyGynecologic OncologyMolecular OncologyMalignant NeoplasmsOncogene MutationsOvarian CancerOvarian Cancer PharmacotherapyOvarian DisordersOvarian NeoplasiaBrca MutationsBrca1 InactivationHereditary Ovarian Cancer SyndromeMutationOlaparib TherapyOvarian Cancer ChemotherapyOvarian Cancer Treatment